Cargando…

Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective

Autologous chimeric antigen receptor-T (CAR-T) cell therapy has proven itself as an effective therapeutic modality for cancers, especially hematological malignancies and is emerging as a potential candidate for solid organ cancers as well. However, the accessibility to treatment has been limited due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramakrishnan, Sharanya, Kumar, Jeevan, Datta, Suvro Sankha, Radhakrishnan, Vivek, Nair, Reena, Chandy, Mammen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751310/ https://www.ncbi.nlm.nih.gov/pubmed/36531042 http://dx.doi.org/10.3389/fonc.2022.1062296

Ejemplares similares

COVID-19 and haematology services in a cancer centre from a middle-income country: adapting service delivery, balancing the known and unknown during the pandemic
por: Radhakrishnan, Vivek S, et al.
Publicado: (2020)

Outcomes of diffuse large B-cell lymphoma in elderly patients—real-world experience from a middle-income country setting
por: Sarker, Chandrayee, et al.
Publicado: (2021)

Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope
por: Kathrotiya, Manthan, et al.
Publicado: (2020)

PB2223: CLINICOPATHOLOGICAL, CYTOGENETIC AND MOLECULAR CHARACTERISTICS OF PATIENTS WITH NON-CML MYELOPROLIFERATIVE NEOPLASMS: A SINGLE CENTER STUDY
por: Guntiboina, Vinay Anand, et al.
Publicado: (2023)

Impact of COVID-19 on peripheral stem cell collection and preservation at a hematopoietic cell transplant center in India: Experience 2020
por: Javed, Rizwan, et al.
Publicado: (2021)

Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review
por: Radhakrishnan, Vivek S., et al.
Publicado: (2022)

Whole blood derived covid convalescent plasma: A practical experience from India
por: Mandal, Abhijit, et al.
Publicado: (2021)

Rare blood group registry in India-current challenges and future perspectives
por: Datta, Suvro Sankha, et al.
Publicado: (2023)

Challenges in transfusion and the role of Thalidomide in E‐β‐Thalassemia—A case report
por: Javed, Rizwan, et al.
Publicado: (2020)

2697. Fungal Infection Patterns in Hematopoietic Stem Cell Transplant Patients of a Tertiary Care Indian Cancer Hospital
por: Chatterji, Soumyadip, et al.
Publicado: (2023)

Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India
por: Datta, Suvro Sankha, et al.
Publicado: (2015)

Utility of platelet cross-matching in a case of neonatal alloimmune thrombocytopenia associated with a de novo MECOM variant
por: Datta, Suvro Sankha, et al.
Publicado: (2021)

Plasma cell leukaemia: a management conundrum
por: Ravichandran, Sriram, et al.
Publicado: (2014)

Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience
por: Gupta, Nishit, et al.
Publicado: (2019)

Response to post-donation counseling is still a challenge in outdoor voluntary blood donation camps: A survey from a tertiary care regional blood center in Eastern India
por: Mukherjee, Somnath, et al.
Publicado: (2014)

Computer automation for physics chart check should be adopted in clinic to replace manual chart checking for radiotherapy
por: Clouser, Edward L., et al.
Publicado: (2021)

Research agenda in family medicine—should we adopt the Dutch approach?
por: Vinker, Shlomo, et al.
Publicado: (2019)

Patient-specific instrumentation in total knee arthroplasty. Should we adopt it?()
por: Rodrigues, Ana Sofia Teles, et al.
Publicado: (2016)

Head to head: should we adopt the term ‘sessile serrated lesion’?
por: Nagtegaal, Iris D, et al.
Publicado: (2022)

Should we adopt a prognosis-based approach to unexplained infertility?
por: Shingshetty, Laxmi, et al.
Publicado: (2022)

Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
por: Mangla, Ankit
Publicado: (2023)

What should we consider in mixed chimerism after hematopoietic stem cell transplantation?
por: Lim, Jihyang
Publicado: (2011)

Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
por: Stroncek, David F., et al.
Publicado: (2017)

Robots and manufacturing automation /
por: Asfahl, C. Ray, 1938-
Publicado: (1992)

Augmenting adoptive T cell therapy through universal chimeric costimulators
por: Hanada, Ken-ichi, et al.
Publicado: (2013)

Chronic low back pain: should we be adopting novel analgesic techniques?
por: Morais, Inês Gonçalves, et al.
Publicado: (2020)

Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
por: Sankha Datta, S., et al.
Publicado: (2022)

When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors?
por: Marasco, Matteo, et al.
Publicado: (2023)

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
por: Fan, Mingxue, et al.
Publicado: (2017)

Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges
por: Iyer, Rohin K., et al.
Publicado: (2018)

Large-scale manufacturing of base-edited chimeric antigen receptor T cells
por: Woodruff, Rosie, et al.
Publicado: (2023)

Induction and Monitoring of Adoptive Delayed-Type Hypersensitivity in Rats
por: Beeton, Christine, et al.
Publicado: (2007)

Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
por: Shi, Huan, et al.
Publicado: (2014)

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering
por: Oberschmidt, Olaf, et al.
Publicado: (2019)

Electronic product design for automated manufacturing
por: Stillwell, Richard
Publicado: (1989)

Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies
por: Ganeeva, Irina, et al.
Publicado: (2022)

Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
por: Stock, Sophia, et al.
Publicado: (2019)

Late adopters of the electronic health record should move now
por: Rumball-Smith, Juliet, et al.
Publicado: (2020)

Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer
por: Obajdin, J., et al.
Publicado: (2020)

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma
por: Supimon, Kamonlapat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4r6srm5fvq5jebv7tuogl3uli